Latham & Watkins and Goldfarb Seligman & Co. represented Itamar Medical in the transaction. Cooley and Gornitzky & Co. advised ZOLL Medical. Itamar™ Medical Ltd. (Nasdaq...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised REV Group, Inc. and certain selling stockholders in the offering. The secondary offering consisted of 5,500,000 shares of common stock by such selling...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers in the offering. LD Holdings Group LLC executed its offering of $600 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
